We further sought to confirm this observation in vivo using A53T mice injected with either Parkinson’s disease or control RBC-EVs and found a significant increase in the oligomeric α-syn/EAAT2 co-localization (Fig. 6e). Here, SLC1A2 is linked to Parkinson disease.